Chemopreventive Agent Development Clinical Trials

Titlesort ascending Intervention NCT ID Sponsor Status
Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch... Laboratory Biomarker Analysis, Naproxen, Placebo Administration NCT02052908 National Cancer Institute (NCI) Active, not recruiting